Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-25 of 30 for your search:
Cancer Type/Condition:
Breast cancer, female
Trial Type:
Prevention
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Exemestane in Postmenopausal Women at Increased Risk of Developing Breast Cancer
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
35 and over
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
CAN-NCIC-MAP3
, PFIZER-EXEAPO-0028-150, ExCel, NCT00083174, MAP3
2.
Phase III Randomized Study of Continuous Letrozole Versus Intermittent Letrozole in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive, Early-Stage Breast Cancer After Completion of 4 to 6 Years of Prior Adjuvant Endocrine Therapy
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
Postmenopausal
Sponsor:
Other
Protocol IDs:
IBCSG-35-07
, IBCSG-35-07, BIG-1-07-SOLE, EUDRACT-2007-001370-88, NCT00553410
3.
Phase III Randomized Study of Letrozole in Preventing Breast Cancer in Postmenopausal Women With the BRCA1/BRCA2 Mutation
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
40 to 69
Sponsor:
Other, Pharmaceutical / Industry
Protocol IDs:
FNCLCC-ONCO-03/0701
, FNCLCC-ONCO 03/0701 - LIBER, EU-20806, NOVARTIS-FNCLCC-ONCO 03/0701, NCT00673335
4.
Randomized Study of Prophylactic Cranial Radiotherapy in Women With Metastatic or Locally Advanced Breast Cancer Previously Treated With Trastuzumab (Herceptin®) and Taxane Chemotherapy
Phase:
Phase III
Type:
Prevention, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
ACCOG-HER-PCI
, ACCOG-HER-PCI, ISRCTN64624715, EU-20822, NCT00639366
5.
Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
30 to 75
Sponsor:
Other
Protocol IDs:
GD-10-08
, NCT00808522
6.
Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
12 to 26
Sponsor:
Other
Protocol IDs:
RCH CA27091
, NCT00964210
7.
Phase II Pilot Chemoprevention Study of Deslorelin in Combination With Low-Dose Add-Back Estradiol and Testosterone in Premenopausal Women With or Without a BRCA Gene Mutation Who Are at High Risk for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
21 to 48
Sponsor:
NCI
Protocol IDs:
CHNMC-IRB-02164
, NCT00080756
8.
Phase II Study of Exemestane in Postmenopausal Women at High Risk for Invasive Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
Postmenopausal
Sponsor:
NCI
Protocol IDs:
GUMC-2007-313
, NCI-04-C-0044, NCT00085072, GUMC-2007-313, GT 07-313, 2007-313
9.
Soy Protein and Breast Cancer Risk Reduction
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 40
Sponsor:
Other
Protocol IDs:
02-422
, Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, NIH NCRR GCRC M01 RR00073, NCT00204477
10.
Soy Isoflavones and Breast Cancer Risk Reduction
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 42
Sponsor:
NCI, Other
Protocol IDs:
03-260
, UTMB GCRC #635, NIH R01-CA95545, NIH NCRR GCRC M01 RR00073, NCT00204490
11.
Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Diagnostic, Prevention
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
BRSNSTU0010
, NCT00285857
12.
Phase II Chemoprevention Study of Simvastatin in Women at High Risk of Developing a New Breast Cancer After Undergoing Surgical Resection for Ductal Carcinoma in Situ or Stage I-III Invasive Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J0485
, J0485, JHOC-SKCCC-J0485, JHOC-04100404, NCT00334542
13.
Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Approved-not yet active
Age:
30 to 90
Sponsor:
Other
Protocol IDs:
102/07
, NCT00496288
14.
Study of Breast Cancer Prevention by Letrozole in High Risk Women
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
30 to 69
Sponsor:
NCI, Other
Protocol IDs:
10587
, NCT00579826
15.
Phase II Study of Acolbifene Hydrochloride in Premenopausal Women At High Risk for Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
30 to 55
Sponsor:
NCI
Protocol IDs:
WCCC-UW-CO06101
, KUMC-HSC-10588, KUMC HSC 10588, WCCC-UWI05-6-01, NCT00853996
16.
Vitamin D in Postmenopausal Women at High Risk for Breast Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
Protocol Dated 121308
, AAAD3638, NCT00859651
17.
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
RSRB00025478
, NCT00904033
18.
Statins and Breast Cancer Biomarkers
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
35 to 55
Sponsor:
Other
Protocol IDs:
V0407
, CHRMS#: 05-059, NCT00914017
19.
Green Tea and Reduction of Breast Cancer Risk
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
50 to 64
Sponsor:
NCI, Other
Protocol IDs:
0806M36121
, NCT00917735
20.
Phase I Pilot Chemoprevention Study of IH636 Grape Seed Proanthocyanidin Extract in Healthy Postmenopausal Women at High Risk of Developing Breast Cancer
Phase:
Phase I
Type:
Prevention
Status:
Active
Age:
40 to 75
Sponsor:
NCI
Protocol IDs:
CHNMC-IRB-03178
, NCT00100893
21.
Green Tea Extract in Treating Women With Hormone Receptor-Negative Stage I, Stage II, or Stage III Breast Cancer
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention, Treatment
Status:
Active
Age:
21 to 65
Sponsor:
NCI, Other
Protocol IDs:
CDR0000557580
, MDA-MDA04-4-01, MDA-2006-0521, CPMC-IRB-AAAB7638, NCT00516243
22.
Atorvastatin in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 to 72
Sponsor:
NCI, Other
Protocol IDs:
CDR0000588191
, MDA-MDA05-6-01, MDA-2006-0185, NCT00637481
23.
Randomized Prevention Study of Anastrozole in Postmenopausal Women at Increased Risk of Breast Cancer
Phase:
No phase specified
Type:
Prevention
Status:
Active
Age:
40 to 70
Sponsor:
Other
Protocol IDs:
CRUK-IBIS-IIB
, EU-20227, NCT00078832, IBCSG-31-03-PREV, EUDRACT-2004-003991-12
24.
Randomized Study of the Effect of a Reduced-Calorie Diet and/or Exercise Program on Risk Factors for Breast Cancer Development in Overweight or Obese Postmenopausal Women
Phase:
No phase specified
Type:
Behavioral study, Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
50 to 75
Sponsor:
NCI
Protocol IDs:
FHCRC-PHS-1960.00
, FHCRC-1960, PHS 1960.00, NCT00470119
25.
Pilot Study of Standardized Freeze-Dried Table Grape Powder on Plasma Estrogen Levels in Postmenopausal Women Participating in the Mayo Mammography Health Study
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC0536
, MC0536, NCT00611104
Select All on Page
1
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
